Next generation sequencing for cancer Propelling the market of NGS-Based RNA-Seq Market

According to a new market research study titled ‘NGS-Based RNA-Seq Market to 2027 – Global Analysis and Forecasts by Product & Services, Technology, Application and End User, the global NGS-based RNA-seq market is expected to reach US$ 7,984.90 Mn in 2027 from US$ 1,240.87 Mn in 2017. The market is estimated to grow with a CAGR of 19.3% from 2018-2027. The report highlights the trends prevalent in the global NGS-based RNA-seq market and the factors driving the market along with those that act as deterrents to its growth. The market is expected to grow due to the reduced cost of genome sequencing, advancements in sequencing technology and next generation sequencing for cancer, are the major factors that anticipated to propel the growth for the NGS-based RNA-seq market in the forecast period. However, the risks related to genetic data and high cost of NGS instruments is expected to act as a major challenges hindering the market growth in the forecast period.

The recent development in technologies has enabled companies to produce sequencing in a single day at the cost of about $15 per sample. Genome library automation includes the incorporation of LIMS that is used to provide tracking mechanisms during the sample preparation and incorporation of barcodes to the micro RNA libraries at the PCR step. It results in effective delivery of target and whole genome data for thousands of samples at a reasonable cost. For instance, Illumina’s Multiples Sequencing permits large numbers of libraries to be assembled and sequenced concurrently during a single run on a high-throughput instrument. The barcodes are added to the fragments at the time of next generation sequencing library preparation. The barcode attached with the DNA fragments assists in the identification and sorting the final data for analysis. This is a cost effective treatment and provides high-quality data by maintaining the read lengths of the unknown sequences. Therefore, the NGS-based RNA-seq market is anticipated to grow due to using barcode scanning for long reads sequences, in the forecast period.

Global NGS-based RNA-seq market, based on the application was segmented into diagnostics, drug discovery, precision medicine and others. In 2017, the diagnostics segment held the largest and fastest growing segment of the market.

The major players operating in the market of NGS-based RNA-seq include Illumina, Inc., Thermo Fisher Scientific Inc., Pacific Biosciences of California, Inc., Qaigen, F. Hoffmann-La Roche AG, Agilent Technologies, Inc., BGI, Oxford Nanopore Technologies, Perkinelmer, Inc. and Eurofins Scientific among others. The global NGS-based RNA-seq market is highly competitive and driven by advanced products launch and approvals. For instance, in April 2018, BGI launched NGS-based HPV genotyping product, Sentis-HPVseq, to the global market that provides detection of both high-risk and low-risk HPV types, which is recognized as an effective method for primary cervical cancer screening.

The report segments the global NGS-based RNA-seq market as follows:

Global NGS-Based RNA-Seq Market – By Product & Services

• Sample Preparation
  • Method
    • Manual Method
    • Automated Method
  • Workflow Step
    • Library Preparation & Target Enrichment
    • Fragmentation, End Repair & Size Selection
    • Quality Control
• Sequencing Services
• Sequencing Platform & Consumables
• Data Analysis, Storage & Management

Global NGS-Based RNA-Seq Market – By Technology

• Sequencing By Synthesis
• Nanopore Sequencing
• Ion Semiconductor Sequencing
• Single-Molecule Real-Time (SMRT) Sequencing

Global NGS-Based RNA-Seq Market – By Application

• Diagnostics
• Drug Discovery
• Precision Medicine
• Others

Global NGS-Based RNA-Seq Market – By End User

• Hospitals & Clinics
• Research Centers and Academic & Government Institutes
• Biotechnology & Pharmaceutical Companies
• Others

Global NGS-Based RNA-Seq Market – By Geography

• North America
  • • U.S.
    • Canada
    • Mexico
• Europe
  • • UK
    • Germany
    • France
• Asia Pacific (APAC)
  • • Japan
    • China
    • India
• Middle East & Africa (MEA)
  • • U.A.E
    • Saudi Arabia
    • South Africa
• South and Central America (SCAM)
  • • Brazil